science policy, public health

From immigration reform to climate change amelioration, researchers and science policy advocates share their hopes for 2021 and beyond.

The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.

COVID-19 has laid bare some of the pitfalls of the relationship between scientific experts and policymakers—but some researchers say there are ways to make it better.

The World Health Organization warns that a lack of data on how many people have the disease could undermine containment and mitigation efforts in many countries.

A new analysis finds that ice melt in Greenland and Antarctica could lead to increases of 2 meters by the end of the century if carbon emissions are not reduced.

FDA researchers report that multiple active ingredients wind up in users’ bloodstream and recommend toxicology testing to investigate the clinical significance of the findings.

The National Science and Technology Council will bring together agency leaders to “focus on improving the safety, integrity, and productivity of research settings.”

The fast-growing fish can now be raised and sold in the US, although it’s likely to be some time before the product hits the market.

Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

Small research groups tend to beat large collaborations when it comes to producing innovative projects and breakthrough discoveries.

Most of the 34 patients are under 10 years old, and almost all have been confirmed as unvaccinated against the virus.

President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

Steven Chu, the president-elect of the scientific organization, is a Nobel laureate and physicist at Stanford University.

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

The university argues that the law prohibiting the use of aborted fetal tissue for research is unconstitutional.

The communications director at the National Institute of Environmental Health Sciences says news reports of the changes are overblown.

The pick—Georgia Public Health Commissioner and physician Brenda Fitzgerald—is an experienced public health leader, but lacks research chops. 

A point system seeks to ensure that funding is spread more evenly among researchers, especially early- and mid-career scientists.